Your browser is no longer supported. Please, upgrade your browser.
Settings
VLRX Valeritas Holdings, Inc. daily Stock Chart
VLRX [NASD]
Valeritas Holdings, Inc.
Index- P/E- EPS (ttm)-29.24 Insider Own0.41% Shs Outstand6.44M Perf Week-14.42%
Market Cap17.19M Forward P/E- EPS next Y-7.15 Insider Trans- Shs Float4.28M Perf Month-11.00%
Income-51.20M PEG- EPS next Q-2.84 Inst Own59.00% Short Float9.43% Perf Quarter-55.79%
Sales26.70M P/S0.64 EPS this Y80.90% Inst Trans- Short Ratio0.70 Perf Half Y-67.26%
Book/sh0.29 P/B9.21 EPS next Y25.70% ROA-90.90% Target Price13.00 Perf Year-91.19%
Cash/sh5.70 P/C0.47 EPS next 5Y- ROE- 52W Range2.10 - 33.80 Perf YTD-58.99%
Dividend- P/FCF- EPS past 5Y- ROI-76.90% 52W High-92.10% Beta-
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin47.10% 52W Low27.14% ATR0.30
Employees82 Current Ratio3.30 Sales Q/Q4.90% Oper. Margin- RSI (14)42.51 Volatility6.46% 9.53%
OptionableNo Debt/Eq27.67 EPS Q/Q91.20% Profit Margin- Rel Volume0.42 Prev Close2.70
ShortableYes LT Debt/Eq27.60 EarningsAug 08 AMC Payout- Avg Volume580.22K Price2.67
Recom1.00 SMA20-7.01% SMA50-25.17% SMA200-71.07% Volume241,768 Change-1.11%
Jul-05-18Initiated Oppenheimer Outperform $3.50
Jul-11-19 11:30AM  A Look At Benzinga Pro's Most-Searched Tickers For July 11, 2019 Benzinga -17.60%
Jul-08-19 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population GlobeNewswire
Jun-27-19 07:00AM  Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable Insulin Delivery Device GlobeNewswire
Jun-24-19 07:00AM  Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold GlobeNewswire -5.52%
Jun-13-19 01:59PM  Edited Transcript of VLRX earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-10-19 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus Delivery GlobeNewswire
May-31-19 04:05PM  Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire -5.78%
May-29-19 07:00AM  Valeritas to Participate in the American Diabetes Associations 79th Scientific Sessions; Company Reiterates Second Quarter and Full-Year 2019 Revenue Guidance GlobeNewswire +37.81%
May-28-19 07:00AM  American Diabetes Association Includes Disposable Patch-Like Device, such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019 GlobeNewswire +22.51%
May-22-19 07:00AM  Valeritas V-Go® Demonstrates Positive Impact in Diabetes Quality Performance Measures in an Older Adult Population GlobeNewswire -26.26%
May-17-19 07:00AM  Valeritas Announces Reverse Stock Split GlobeNewswire -16.01%
May-13-19 07:00AM  Valeritas Exhibits at Taking Control of Your Diabetes Conferences GlobeNewswire -6.74%
May-09-19 09:05PM  Valeritas Holdings, Inc. (VLRX) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:05PM  Valeritas Announces First Quarter 2019 Financial Results and Updates Full Year 2019 Revenue Guidance GlobeNewswire
May-02-19 10:32AM  Will Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should Know Zacks
07:00AM  Valeritas Expects First Quarter Revenue of $6.4 million GlobeNewswire
Apr-29-19 07:00AM  Valeritas to Present at Upcoming Investor Conferences GlobeNewswire
Apr-26-19 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.5 and Total Daily Insulin Dosage by 14% GlobeNewswire
Apr-22-19 07:00AM  Valeritas to Report First Quarter 2019 Financial Results on May 9, 2019 GlobeNewswire
Apr-08-19 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates 24% Reduction in Total Daily Insulin Dosage and Lower A1C Compared to Standard Insulin Treatment GlobeNewswire +9.53%
Apr-01-19 07:00AM  Valeritas partners with the American Association of Diabetes Educators (AADE) GlobeNewswire
Mar-28-19 07:00AM  Valeritas Announces V-Go® Distribution Agreement in Israel GlobeNewswire
Mar-12-19 07:00AM  Valeritas to Present at the Oppenheimer 29th Annual Healthcare Conference GlobeNewswire
Mar-11-19 02:05PM  Edited Transcript of VLRX earnings conference call or presentation 5-Mar-19 9:30pm GMT Thomson Reuters StreetEvents -6.08%
Mar-05-19 04:05PM  Valeritas Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire +8.42%
02:30PM  Valeritas Holdings, Inc. to Host Earnings Call ACCESSWIRE
Feb-28-19 04:05PM  Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Feb-22-19 11:14AM  Healthcare Stocks Leading the Sector ACCESSWIRE
Feb-21-19 09:25AM  Tech Stocks to Watch Today ACCESSWIRE +15.04%
07:00AM  Switching to Valeritas V-Go® Wearable Insulin Delivery Device from Insulin Pen Devices for Basal-Bolus Therapy Improved Glycemic Control with Less Insulin GlobeNewswire
Feb-19-19 07:00AM  Valeritas to Present at Upcoming Investor Conferences GlobeNewswire
Feb-12-19 07:00AM  Valeritas to Report Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019 GlobeNewswire
Jan-14-19 09:15AM  4 Healthcare Stocks Setting The Pace On Monday (1/14/19) ACCESSWIRE
07:00AM  Valeritas Announces V-Go® Received Preferred Status on OptumRx Formularies GlobeNewswire
Jan-03-19 08:35AM  4 Healthcare Stocks Gaining Speed on Thursday (1/3/19) ACCESSWIRE +5.59%
07:07AM  Valeritas Announces V-Go® is Preferred on Humana Part D Formularies GlobeNewswire
Dec-18-18 06:38PM  Edited Transcript of VLRX earnings conference call or presentation 9-Nov-18 1:30pm GMT Thomson Reuters StreetEvents -8.11%
08:35AM  5 Beaten-Down Medical Product Stocks to Rebound in 2019 Zacks
Nov-28-18 07:00AM  Valeritas CEO John Timberlake to Participate as a Panelist on Exploring Innovation in Diabetes Tech, at DeviceTalks West Conference GlobeNewswire +6.94%
Nov-26-18 07:00AM  Study Supports Valeritas V-Go® Can Improve Glycemic Control in Type 2 Patients When Using an Easy to Follow Physician-Driven Insulin Titration Algorithm GlobeNewswire -10.17%
Nov-15-18 08:13PM  Valeritas Announces Pricing of $36 Million Public Offering GlobeNewswire -29.20%
Nov-14-18 07:35AM  Investor Expectations to Drive Momentum within Townsquare Media, Koss, ESSA Pharma, MVC Capital, Valeritas, and Sonic Foundry Discovering Underlying Factors of Influence GlobeNewswire -20.44%
Nov-13-18 07:00AM  Valeritas Signs Exclusive Middle East Distribution Agreement with Julphar GlobeNewswire -14.39%
Nov-12-18 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese GlobeNewswire -6.94%
Nov-09-18 07:00AM  Valeritas Reports Record Revenue for the Third Quarter 2018 GlobeNewswire -10.00%
Nov-05-18 07:00AM  Valeritas to Report Third Quarter 2018 Results November 9, 2018 GlobeNewswire
Oct-19-18 07:00AM  Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy GlobeNewswire
Oct-17-18 07:00AM  Valeritas Wins Fifth Consecutive Cardinal Health Supply Chain Excellence Award GlobeNewswire
Oct-16-18 08:25AM  Valeritas Holdings Revenues Grow on Acceptance of V-Go for Insulin, Analyst Report ACCESSWIRE
Oct-15-18 07:00AM  Valeritas Expects to Report Record Revenue for Third Quarter 2018 GlobeNewswire -7.35%
Oct-11-18 07:00AM  Valeritas is a Contributing Supporter of the Interactive Insulin Workshop at MEDS East Summit GlobeNewswire
Oct-10-18 07:00AM  Persistent Use of Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates Significant Clinical & Economic Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes GlobeNewswire
Oct-02-18 07:00AM  Valeritas V-Go® Demonstrates Benefits Versus Multiple Daily Injections in Patients with Type 2 Diabetes GlobeNewswire
Sep-26-18 08:00AM  Valeritas Begins Medical Device Registration Process in China for Its V-Go® Wearable Insulin Delivery Device GlobeNewswire +32.00%
Aug-23-18 07:00AM  Valeritas Announces that V-Go® Insulin Delivery Device Has Launched in Australia GlobeNewswire -9.17%
Aug-21-18 07:39PM  Edited Transcript of VLRX earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents -6.43%
Aug-07-18 04:05PM  Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth GlobeNewswire
02:30PM  Valeritas Holdings, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 07:00AM  Valeritas Announces V-Go® Distribution Agreement in Czech Republic and Slovakia GlobeNewswire
Aug-02-18 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical Benefits in Patients with Uncontrolled Type 2 Diabetes Previously Treated with Multiple Daily Injections GlobeNewswire
Aug-01-18 07:00AM  Valeritas Announces that V-Go® Insulin Delivery is Now Available in New Zealand GlobeNewswire
Jul-31-18 07:31AM  Free Pre-Market Technical Recap on DENTSPLY SIRONA and Three Additional Medical Supplies Stocks ACCESSWIRE
Jul-25-18 07:00AM  Valeritas, Makers of V-Go® Insulin Delivery, is a Contributing Supporter of the Interactive Insulin Workshop at Two MEDS Conferences GlobeNewswire
Jul-24-18 07:00AM  Valeritas to Report Second Quarter 2018 Results August 7, 2018 GlobeNewswire
Jul-05-18 12:41PM  Valeritas Stock Should More Than Double, Oppenheimer Says Benzinga +8.88%
Jun-29-18 07:20AM  Free Technical Research on Valeritas Holdings and Three More Medical Supplies Equities ACCESSWIRE
Jun-26-18 08:05AM  Valeritas Holdings, New Study Results Pump Up V-Go Insulin Delivery Device ACCESSWIRE -6.83%
Jun-25-18 07:00AM  Valeritas ENABLE Study Demonstrates Significant Clinical Benefits of V-Go in Patients with Type 2 Diabetes Who Switched from Insulin Pens and Syringes GlobeNewswire +13.38%
May-23-18 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates Positive Clinical and Economic Benefits in Patients with Type 2 Diabetes GlobeNewswire
May-22-18 07:30AM  Blog Exposure - Valeritas Presented Positive Clinical Results from Two New Studies Assessing V-Go Wearable Insulin Delivery Device in Type-2 Diabetes ACCESSWIRE
07:10AM  Free Daily Technical Summary Reports on Valeritas and Three Other Medical Supplies Stocks ACCESSWIRE
May-21-18 07:00AM  Valeritas Announces V-Go® Distribution Agreement in Austria and Germany GlobeNewswire
May-18-18 07:00AM  Valeritas Announces Positive Clinical Results Across Two New Studies Evaluating V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes GlobeNewswire +10.42%
03:42AM  Edited Transcript of VLRX earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-16-18 07:50AM  Free Post Earnings Research Report: Integras Quarterly Sales Surged 38%; Adjusted EPS Soared 49% ACCESSWIRE
May-14-18 07:00AM  Valeritas V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes GlobeNewswire
May-09-18 04:01PM  Valeritas Reports Record First Quarter Revenue with 32% Year-over-Year Growth and Gross Margins Expand to Record 47.6% GlobeNewswire
May-01-18 07:00AM  Valeritas to Report First Quarter 2018 Results on May 9, 2018 GlobeNewswire
Apr-30-18 07:00AM  Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets GlobeNewswire
Apr-24-18 07:00AM  Valeritas Announces Pricing of $24 Million Public Offering of Common Stock GlobeNewswire -35.69%
Apr-20-18 07:00AM  Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM GlobeNewswire +76.27%
Apr-17-18 07:00AM  Valeritas Announces V-Go® Distribution Agreement in Australia and New Zealand GlobeNewswire +69.35%
Mar-02-18 07:00AM  Valeritas to Present at Upcoming Investor Conferences GlobeNewswire
Feb-28-18 06:48PM  Valeritas Holdings Inc (VLRX) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com +7.80%
Feb-27-18 04:21PM  Edited Transcript of VLRX earnings conference call or presentation 26-Feb-18 9:30pm GMT Thomson Reuters StreetEvents -5.37%
Feb-26-18 04:03PM  Valeritas Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
12:15PM  Valeritas Holdings, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-18 07:01AM  Valeritas Announces V-Go® Distribution Agreement in Italy with Movi SpA GlobeNewswire
Feb-15-18 08:02AM  Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Ins... GlobeNewswire
Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.